US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quoin Pharmaceuticals

5.57

+0.580011.62%

Post-market: 5.40-0.1670-3.00%19:30 EDT

Volume:72.11K

Turnover:391.82K

Market Cap:11.19M

PE:-0.53

High:5.88

Open:5.29

Low:5.02

Close:4.99

52wk High:41.80

52wk Low:3.25

Shares:2.01M

Float Shares:1.63M

Volume Ratio:2.98

T/O Rate:4.42%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-10.4278

EPS(LYR):-14.7963

ROE:-575.73%

ROA:-114.60%

PB:2.84

PE(LYR):-0.38

Loading ...

Overview Company News Filings

Quoin Pharmaceuticals Completes Establishment Of Japanese Subsidiary To Advance Commercial Readiness For Qrx003

Quoin Pharmaceuticals establishes Japan subsidiary to support QRX003 commercialization plans

Quoin reports positive pediatric data in Netherton Syndrome program

Quoin says QRX003 improves 4 of 6 pediatric Netherton syndrome patients in compassionate use program

Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program

Quoin Pharmaceuticals' Skin Disorder Drug Receives Orphan Drug Designation in Japan

MT Newswires Live

Quoin says Japan MHLW grants orphan drug status to QRX003 for Netherton syndrome

Quoin Pharmaceuticals submits QRX003 IND application to FDA

Quoin Pharmaceuticals submits FDA IND for QRX003 in Peeling Skin Syndrome

Quoin Pharmaceuticals (QNRX) Receives a Buy from Maxim Group

Quoin Pharmaceuticals Q1 EPS $(1.77) Misses $(1.72) Estimate

Benzinga Earnings

Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results

Quoin Pharmaceuticals Ltd expected to post a loss of $1.93 a share - Earnings Preview

Quoin Pharmaceuticals Initiated at Buy by LUCID CAPITAL MARKETS

Quoin Pharmaceuticals initiated with a Buy at Lucid Capital

Quoin Pharma to report Q1 results, provide corporate update May 7

Quoin Pharmaceuticals Provides Clinical And Regulatory Update For Qrx009 Topical Rapamycin Development Programs

Quoin plans investigator-led trial of QRX009 topical rapamycin in pachyonychia congenita

Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs

Quoin’s QRX003 Trial Moves Forward In Rare Skin Disease, Keeping QNRX On Investor Watch

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/QNRX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"QNRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QNRX\",,,,,undefined,":{"symbol":"QNRX","market":"US","secType":"STK","nameCN":"Quoin Pharmaceuticals","latestPrice":5.57,"timestamp":1787342400000,"preClose":4.99,"halted":0,"volume":72107,"hourTrading":{"tag":"盘后","latestPrice":5.403,"preClose":5.57,"latestTime":"19:30 EDT","volume":326,"amount":1794.503,"timestamp":1787355005322,"change":-0.167,"changeRate":-0.029982,"amplitude":0.029982},"delay":0,"changeRate":0.11623246492985972,"floatShares":1629700,"shares":2008400,"eps":-10.427843,"marketStatus":"Market Closed","change":0.58,"latestTime":"08-21 16:00:00 EDT","open":5.29,"high":5.88,"low":5.02,"amount":391818.7445319,"amplitude":0.172345,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-10.427843,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":35,"exchange":"NASDAQ","adjPreClose":4.99,"postHourTrading":{"tag":"盘后","latestPrice":5.403,"preClose":5.57,"latestTime":"19:30 EDT","volume":326,"amount":1794.503,"timestamp":1787355005322,"change":-0.167,"changeRate":-0.029982,"amplitude":0.029982},"volumeRatio":2.98044094547255},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QNRX\",,,,,undefined,":{"symbol":"QNRX","floatShares":1629700,"roa":"-114.60%","roe":"-575.73%","lyrEps":-14.79626,"volumeRatio":2.98044094547255,"shares":2008400,"dividePrice":0,"high":5.88,"amplitude":0.172345,"preClose":4.99,"low":5.02,"week52Low":3.25,"pbRate":"2.84","week52High":41.8,"institutionHeld":0,"latestPrice":5.57,"eps":-10.427843,"divideRate":0,"volume":72107,"delay":0,"ttmEps":-10.427843,"open":5.29,"prevYearClose":14.43,"prevWeekClose":5.09,"prevMonthClose":4.45,"prevQuarterClose":4.84,"fiveDayClose":5.09,"twentyDayClose":4.28,"sixtyDayClose":5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/QNRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"QNRX","fiscalQuarterEnding":"2026/06","expectedEps":-1.83,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"pre","actualEps":-1.9},{"market":"US","date":"2026-05-07","symbol":"QNRX","fiscalQuarterEnding":"2026/03","expectedEps":-1.8,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-1.77},{"market":"US","date":"2026-03-26","symbol":"QNRX","fiscalQuarterEnding":"2025/12","expectedEps":-6.42,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"pre","actualEps":-14.8},{"market":"US","date":"2025-11-06","symbol":"QNRX","fiscalQuarterEnding":"2025/09","expectedEps":-6.36,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-6.71},{"market":"US","date":"2025-08-07","symbol":"QNRX","fiscalQuarterEnding":"2025/06","expectedEps":-6.83,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-6.28}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"QNRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"QNRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1781582400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/QNRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"QNRX","date":"2026-08-21","current":-0.534147,"percent":0.421053,"low":-17.346367,"twenty":-0.733573,"median":-0.498316,"eighty":-0.345799,"high":-0.000007,"avg":-0.75007,"sd":1.464051,"marketCap":10022000},"quantilePoints":[{"date":"2021-10-29","current":-17.346367,"twenty":-17.346367,"median":-17.346367,"eighty":-17.346367,"marketCap":97148313},{"date":"2021-11-05","current":-12.667021,"twenty":-16.958905,"median":-15.73691,"eighty":-14.60433,"marketCap":70941637},{"date":"2021-11-12","current":-8.658281,"twenty":-16.765174,"median":-12.667021,"eighty":-10.28264,"marketCap":48490695},{"date":"2021-11-19","current":-7.615115,"twenty":-14.708646,"median":-10.506176,"eighty":-8.241015,"marketCap":42648443},{"date":"2021-11-26","current":-3.943296,"twenty":-14.625193,"median":-8.598672,"eighty":-7.442247,"marketCap":37807719},{"date":"2021-12-03","current":-2.811666,"twenty":-13.054483,"median":-8.241015,"eighty":-3.931109,"marketCap":26957822},{"date":"2021-12-10","current":-3.055402,"twenty":-11.760956,"median":-7.592761,"eighty":-3.245167,"marketCap":29294723},{"date":"2021-12-17","current":-1.862838,"twenty":-10.890658,"median":-4.02164,"eighty":-3.025805,"marketCap":17860600},{"date":"2021-12-23","current":-1.549649,"twenty":-10.461469,"median":-3.943296,"eighty":-2.794256,"marketCap":16525228},{"date":"2021-12-31","current":-1.424425,"twenty":-9.308025,"median":-3.294786,"eighty":-1.787652,"marketCap":15189856},{"date":"2022-01-07","current":-1.627915,"twenty":-8.58675,"median":-3.203384,"eighty":-1.577825,"marketCap":17359836},{"date":"2022-01-14","current":-1.267895,"twenty":-8.485414,"median":-3.107631,"eighty":-1.488603,"marketCap":13520641},{"date":"2022-01-21","current":-1.0331,"twenty":-8.366195,"median":-2.876952,"eighty":-1.447905,"marketCap":11016819},{"date":"2022-01-28","current":-0.970488,"twenty":-8.163523,"median":-2.768142,"eighty":-1.377466,"marketCap":10349133},{"date":"2022-02-04","current":-1.111365,"twenty":-7.874416,"median":-1.976001,"eighty":-1.235023,"marketCap":11851426},{"date":"2022-02-11","current":-1.085306,"twenty":-7.597232,"median":-1.674874,"eighty":-1.127775,"marketCap":11573542},{"date":"2022-02-18","current":-1.061713,"twenty":-7.314087,"median":-1.573129,"eighty":-1.113525,"marketCap":11321943},{"date":"2022-02-25","current":-0.865099,"twenty":-6.348012,"median":-1.498777,"eighty":-1.105103,"marketCap":9225287},{"date":"2022-03-04","current":-0.904422,"twenty":-4.019899,"median":-1.479211,"eighty":-1.071673,"marketCap":9644618},{"date":"2022-03-11","current":-1.163952,"twenty":-3.999007,"median":-1.447905,"eighty":-1.061713,"marketCap":12412205},{"date":"2022-03-18","current":-1.163952,"twenty":-3.931109,"median":-1.416599,"eighty":-1.037796,"marketCap":12412205},{"date":"2022-03-25","current":-1.148223,"twenty":-3.765718,"median":-1.381379,"eighty":-1.057606,"marketCap":12244472},{"date":"2022-04-01","current":-1.053848,"twenty":-3.297397,"median":-1.299201,"eighty":-1.053848,"marketCap":11238077},{"date":"2022-04-08","current":-0.928015,"twenty":-3.283469,"median":-1.222936,"eighty":-1.035677,"marketCap":9896217},{"date":"2022-04-14","current":-0.476722,"twenty":-3.255613,"median":-1.205283,"eighty":-1.00962,"marketCap":10231682},{"date":"2022-04-22","current":-0.410293,"twenty":-3.203384,"median":-1.163952,"eighty":-0.975203,"marketCap":8805956},{"date":"2022-04-29","current":-0.313073,"twenty":-3.185975,"median":-1.153274,"eighty":-0.954835,"marketCap":6719363},{"date":"2022-05-06","current":-0.308697,"twenty":-3.15986,"median":-1.132494,"eighty":-0.920151,"marketCap":6625433},{"date":"2022-05-13","current":-0.243519,"twenty":-3.055402,"median":-1.120697,"eighty":-0.880828,"marketCap":5226544},{"date":"2022-05-20","current":-0.246137,"twenty":-2.907419,"median":-1.111365,"eighty":-0.857235,"marketCap":5282735},{"date":"2022-05-27","current":-0.275987,"twenty":-2.846486,"median":-1.107451,"eighty":-0.468907,"marketCap":5310410},{"date":"2022-06-03","current":-0.26812,"twenty":-2.81863,"median":-1.087972,"eighty":-0.44468,"marketCap":5159040},{"date":"2022-06-10","current":-0.203983,"twenty":-2.776847,"median":-1.085306,"eighty":-0.385285,"marketCap":3924940},{"date":"2022-06-17","current":-0.152291,"twenty":-2.489587,"median":-1.07351,"eighty":-0.319364,"marketCap":2930308},{"date":"2022-06-24","current":-0.155212,"twenty":-2.221478,"median":-1.061713,"eighty":-0.298542,"marketCap":2986515},{"date":"2022-07-01","current":-0.267305,"twenty":-1.953368,"median":-1.056579,"eighty":-0.277405,"marketCap":5143349},{"date":"2022-07-08","current":-0.231074,"twenty":-1.787652,"median":-1.053848,"eighty":-0.273302,"marketCap":4446216},{"date":"2022-07-15","current":-0.178755,"twenty":-1.674874,"median":-1.039542,"eighty":-0.267462,"marketCap":3439525},{"date":"2022-07-22","current":-0.183115,"twenty":-1.65609,"median":-1.030254,"eighty":-0.25072,"marketCap":3523416},{"date":"2022-07-29","current":-0.155517,"twenty":-1.615393,"median":-0.994864,"eighty":-0.244988,"marketCap":2992387},{"date":"2022-08-05","current":-1.0024,"twenty":-1.577825,"median":-0.983067,"eighty":-0.2438,"marketCap":19287705},{"date":"2022-08-12","current":-0.905761,"twenty":-1.530865,"median":-0.979135,"eighty":-0.244988,"marketCap":17428209},{"date":"2022-08-19","current":-1.261787,"twenty":-1.49956,"median":-0.983067,"eighty":-0.24634,"marketCap":22172308},{"date":"2022-08-26","current":-1.00506,"twenty":-1.494864,"median":-1.00373,"eighty":-0.247189,"marketCap":17661059},{"date":"2022-09-02","current":-0.83846,"twenty":-1.488603,"median":-0.983067,"eighty":-0.248209,"marketCap":14733547},{"date":"2022-09-09","current":-1.015985,"twenty":-1.47295,"median":-0.985942,"eighty":-0.249617,"marketCap":17853027},{"date":"2022-09-16","current":-0.999598,"twenty":-1.447905,"median":-1.000999,"eighty":-0.2541,"marketCap":17565075},{"date":"2022-09-23","current":-0.80537,"twenty":-1.447905,"median":-0.994135,"eighty":-0.255867,"marketCap":14152083},{"date":"2022-09-30","current":-0.61506,"twenty":-1.446166,"median":-0.983139,"eighty":-0.262906,"marketCap":10807926},{"date":"2022-10-07","current":-0.604028,"twenty":-1.436253,"median":-0.98189,"eighty":-0.267383,"marketCap":10614062},{"date":"2022-10-14","current":-0.471638,"twenty":-1.42286,"median":-0.968913,"eighty":-0.267782,"marketCap":8287692},{"date":"2022-10-21","current":-0.562656,"twenty":-1.413468,"median":-0.966397,"eighty":-0.2688,"marketCap":9887072},{"date":"2022-10-28","current":-0.529559,"twenty":-1.393119,"median":-0.950476,"eighty":-0.271699,"marketCap":9305479},{"date":"2022-11-04","current":-0.485429,"twenty":-1.358698,"median":-0.943659,"eighty":-0.272858,"marketCap":8530023},{"date":"2022-11-11","current":-0.479672,"twenty":-1.345188,"median":-0.923004,"eighty":-0.274906,"marketCap":9208547},{"date":"2022-11-18","current":-0.459476,"twenty":-1.332632,"median":-0.91334,"eighty":-0.276144,"marketCap":8820819},{"date":"2022-11-25","current":-0.462,"twenty":-1.299201,"median":-0.906739,"eighty":-0.276772,"marketCap":8869285},{"date":"2022-12-02","current":-0.441804,"twenty":-1.267895,"median":-0.903164,"eighty":-0.277827,"marketCap":8481557},{"date":"2022-12-09","current":-0.393836,"twenty":-1.261787,"median":-0.893083,"eighty":-0.277839,"marketCap":7560702},{"date":"2022-12-16","current":-0.386263,"twenty":-1.226868,"median":-0.869031,"eighty":-0.278907,"marketCap":7415304},{"date":"2022-12-23","current":-0.333246,"twenty":-1.219003,"median":-0.857235,"eighty":-0.28331,"marketCap":6397517},{"date":"2022-12-30","current":-0.358492,"twenty":-1.214288,"median":-0.83846,"eighty":-0.285895,"marketCap":6882177},{"date":"2023-01-06","current":-0.366066,"twenty":-1.203717,"median":-0.830267,"eighty":-0.294872,"marketCap":7027575},{"date":"2023-01-13","current":-0.419082,"twenty":-1.196726,"median":-0.751587,"eighty":-0.305389,"marketCap":8045362},{"date":"2023-01-20","current":-0.388787,"twenty":-1.192762,"median":-0.704699,"eighty":-0.310447,"marketCap":7463770},{"date":"2023-01-27","current":-0.393836,"twenty":-1.178108,"median":-0.684013,"eighty":-0.314277,"marketCap":7560702},{"date":"2023-02-03","current":-0.59078,"twenty":-1.163952,"median":-0.661949,"eighty":-0.317723,"marketCap":11341538},{"date":"2023-02-10","current":-0.421607,"twenty":-1.163758,"median":-0.631609,"eighty":-0.320717,"marketCap":8093828},{"date":"2023-02-17","current":-0.353443,"twenty":-1.161409,"median":-0.60749,"eighty":-0.323804,"marketCap":6785245},{"date":"2023-02-24","current":-0.118656,"twenty":-1.156304,"median":-0.591888,"eighty":-0.313675,"marketCap":2277903},{"date":"2023-03-03","current":-0.281484,"twenty":-1.14665,"median":-0.562656,"eighty":-0.29262,"marketCap":5403806},{"date":"2023-03-10","current":-0.522124,"twenty":-1.138785,"median":-0.550992,"eighty":-0.287367,"marketCap":4898302},{"date":"2023-03-17","current":-0.593625,"twenty":-1.130921,"median":-0.551624,"eighty":-0.29122,"marketCap":5569088},{"date":"2023-03-24","current":-0.65651,"twenty":-1.124629,"median":-0.575443,"eighty":-0.294825,"marketCap":6159049},{"date":"2023-03-31","current":-0.60057,"twenty":-1.123056,"median":-0.592995,"eighty":-0.300426,"marketCap":5634244},{"date":"2023-04-06","current":-0.603601,"twenty":-1.116764,"median":-0.60057,"eighty":-0.300426,"marketCap":5662676},{"date":"2023-04-14","current":-0.560679,"twenty":-1.116764,"median":-0.592742,"eighty":-0.308697,"marketCap":5260010},{"date":"2023-04-21","current":-0.580997,"twenty":-1.111365,"median":-0.593625,"eighty":-0.313073,"marketCap":5450622},{"date":"2023-04-28","current":-0.649313,"twenty":-1.111365,"median":-0.598171,"eighty":-0.316082,"marketCap":6091523},{"date":"2023-05-05","current":-0.60259,"twenty":-1.111365,"median":-0.60259,"eighty":-0.320185,"marketCap":5653199},{"date":"2023-05-12","current":-0.55198,"twenty":-1.103538,"median":-0.60158,"eighty":-0.321514,"marketCap":5686369},{"date":"2023-05-19","current":-0.55198,"twenty":-1.10065,"median":-0.595771,"eighty":-0.327238,"marketCap":5686369},{"date":"2023-05-26","current":-0.505982,"twenty":-1.088059,"median":-0.592742,"eighty":-0.333246,"marketCap":5212505},{"date":"2023-06-02","current":-0.499658,"twenty":-1.08792,"median":-0.589505,"eighty":-0.344867,"marketCap":5147361},{"date":"2023-06-09","current":-0.55704,"twenty":-1.087172,"median":-0.580997,"eighty":-0.350289,"marketCap":5738494},{"date":"2023-06-16","current":-0.620978,"twenty":-1.085644,"median":-0.584704,"eighty":-0.352938,"marketCap":6397166},{"date":"2023-06-23","current":-0.676176,"twenty":-1.085306,"median":-0.589505,"eighty":-0.356472,"marketCap":6965803},{"date":"2023-06-30","current":-0.593264,"twenty":-1.083207,"median":-0.591634,"eighty":-0.359502,"marketCap":6111663},{"date":"2023-07-07","current":-0.517481,"twenty":-1.079536,"median":-0.587708,"eighty":-0.361522,"marketCap":5330971},{"date":"2023-07-14","current":-0.54646,"twenty":-1.077168,"median":-0.582224,"eighty":-0.364046,"marketCap":5629506},{"date":"2023-07-21","current":-0.623853,"twenty":-1.07607,"median":-0.587708,"eighty":-0.366571,"marketCap":6426782},{"date":"2023-07-28","current":-0.721599,"twenty":-1.07607,"median":-0.591634,"eighty":-0.36859,"marketCap":7433744},{"date":"2023-08-04","current":-0.757094,"twenty":-1.073339,"median":-0.593264,"eighty":-0.36859,"marketCap":7374510},{"date":"2023-08-11","current":-0.62027,"twenty":-1.070607,"median":-0.595859,"eighty":-0.371115,"marketCap":6041768},{"date":"2023-08-18","current":-0.543243,"twenty":-1.069577,"median":-0.593625,"eighty":-0.376164,"marketCap":5291483},{"date":"2023-08-25","current":-0.538176,"twenty":-1.067876,"median":-0.592742,"eighty":-0.378689,"marketCap":5242122},{"date":"2023-09-01","current":-0.58277,"twenty":-1.065691,"median":-0.589505,"eighty":-0.378689,"marketCap":5676497},{"date":"2023-09-08","current":-0.590878,"twenty":-1.063086,"median":-0.590829,"eighty":-0.378689,"marketCap":5755475},{"date":"2023-09-15","current":-0.569594,"twenty":-1.061713,"median":-0.58823,"eighty":-0.378689,"marketCap":5548159},{"date":"2023-09-22","current":-0.506757,"twenty":-1.061713,"median":-0.585904,"eighty":-0.378689,"marketCap":4936085},{"date":"2023-09-29","current":-0.433865,"twenty":-1.060727,"median":-0.581611,"eighty":-0.380709,"marketCap":4226078},{"date":"2023-10-06","current":-0.427703,"twenty":-1.05818,"median":-0.578696,"eighty":-0.383738,"marketCap":4166055},{"date":"2023-10-13","current":-0.408953,"twenty":-1.055487,"median":-0.574156,"eighty":-0.383738,"marketCap":3983420},{"date":"2023-10-20","current":-0.41554,"twenty":-1.053848,"median":-0.568243,"eighty":-0.383738,"marketCap":4047589},{"date":"2023-10-27","current":-0.435811,"twenty":-1.053848,"median":-0.56578,"eighty":-0.383738,"marketCap":4245033},{"date":"2023-11-03","current":-0.435811,"twenty":-1.053848,"median":-0.56554,"eighty":-0.384243,"marketCap":4245033},{"date":"2023-11-10","current":-0.411508,"twenty":-1.050251,"median":-0.562656,"eighty":-0.384243,"marketCap":4008308},{"date":"2023-11-17","current":-0.498316,"twenty":-1.046658,"median":-0.560987,"eighty":-0.385884,"marketCap":4304279},{"date":"2023-11-24","current":-0.522671,"twenty":-1.041435,"median":-0.560318,"eighty":-0.386263,"marketCap":4514655},{"date":"2023-12-01","current":-0.568388,"twenty":-1.035221,"median":-0.558953,"eighty":-0.387777,"marketCap":4909543},{"date":"2023-12-08","current":-0.568034,"twenty":-1.0331,"median":-0.560318,"eighty":-0.388787,"marketCap":4906483},{"date":"2023-12-15","current":-0.484601,"twenty":-1.031392,"median":-0.558953,"eighty":-0.389637,"marketCap":4185812},{"date":"2023-12-22","current":-0.477732,"twenty":-1.021693,"median":-0.557743,"eighty":-0.390868,"marketCap":4126480},{"date":"2023-12-29","current":-0.588241,"twenty":-1.014712,"median":-0.55704,"eighty":-0.391312,"marketCap":5081023},{"date":"2024-01-05","current":-0.532603,"twenty":-1.010893,"median":-0.55589,"eighty":-0.391312,"marketCap":4600445},{"date":"2024-01-12","current":-0.526889,"twenty":-1.007253,"median":-0.553378,"eighty":-0.393331,"marketCap":4551084},{"date":"2024-01-19","current":-0.454873,"twenty":-1.0057,"median":-0.55198,"eighty":-0.393836,"marketCap":3929036},{"date":"2024-01-26","current":-0.427454,"twenty":-1.003464,"median":-0.551802,"eighty":-0.393836,"marketCap":3692202},{"date":"2024-02-02","current":-0.394309,"twenty":-1.000719,"median":-0.549335,"eighty":-0.39412,"marketCap":3405909},{"date":"2024-02-09","current":-0.38288,"twenty":-0.99632,"median":-0.548588,"eighty":-0.392826,"marketCap":3307187},{"date":"2024-02-16","current":-0.318876,"twenty":-0.989219,"median":-0.547495,"eighty":-0.388787,"marketCap":2754343},{"date":"2024-02-23","current":-0.301732,"twenty":-0.98485,"median":-0.546977,"eighty":-0.385127,"marketCap":2606260},{"date":"2024-03-01","current":-0.314316,"twenty":-0.983153,"median":-0.545642,"eighty":-0.383738,"marketCap":2714953},{"date":"2024-03-08","current":-0.135997,"twenty":-0.983067,"median":-0.543349,"eighty":-0.379908,"marketCap":1174693},{"date":"2024-03-15","current":-0.20704,"twenty":-0.982596,"median":-0.542611,"eighty":-0.378689,"marketCap":1798470},{"date":"2024-03-22","current":-0.381897,"twenty":-0.979215,"median":-0.541631,"eighty":-0.378689,"marketCap":3317373},{"date":"2024-03-28","current":-0.369167,"twenty":-0.97426,"median":-0.540481,"eighty":-0.37767,"marketCap":3206793},{"date":"2024-04-05","current":-0.364923,"twenty":-0.969858,"median":-0.539696,"eighty":-0.377263,"marketCap":3169934},{"date":"2024-04-12","current":-0.326734,"twenty":-0.967338,"median":-0.538176,"eighty":-0.369557,"marketCap":2838196},{"date":"2024-04-19","current":-0.305517,"twenty":-0.96715,"median":-0.536661,"eighty":-0.365152,"marketCap":2653898},{"date":"2024-04-26","current":-0.267328,"twenty":-0.964085,"median":-0.533552,"eighty":-0.358997,"marketCap":2322161},{"date":"2024-05-03","current":-0.309761,"twenty":-0.95419,"median":-0.531461,"eighty":-0.351423,"marketCap":2690758},{"date":"2024-05-10","current":-0.337342,"twenty":-0.951156,"median":-0.528981,"eighty":-0.340821,"marketCap":2930346},{"date":"2024-05-17","current":-0.367202,"twenty":-0.948223,"median":-0.527946,"eighty":-0.340821,"marketCap":3088456},{"date":"2024-05-24","current":-0.34075,"twenty":-0.943728,"median":-0.525421,"eighty":-0.340947,"marketCap":2865976},{"date":"2024-05-31","current":-0.331712,"twenty":-0.943659,"median":-0.525,"eighty":-0.340592,"marketCap":2789958},{"date":"2024-06-07","current":-0.346334,"twenty":-0.928015,"median":-0.523469,"eighty":-0.340703,"marketCap":2912940},{"date":"2024-06-14","current":-0.340703,"twenty":-0.926289,"median":-0.522398,"eighty":-0.340681,"marketCap":2865578},{"date":"2024-06-21","current":-0.295228,"twenty":-0.922433,"median":-0.519905,"eighty":-0.336816,"marketCap":2483103},{"date":"2024-06-28","current":-0.279187,"twenty":-0.920151,"median":-0.518004,"eighty":-0.336018,"marketCap":2348182},{"date":"2024-07-05","current":-0.274313,"twenty":-0.920151,"median":-0.512285,"eighty":-0.333064,"marketCap":2307188},{"date":"2024-07-12","current":-0.307579,"twenty":-0.914702,"median":-0.509745,"eighty":-0.331195,"marketCap":2586980},{"date":"2024-07-15","current":-0.310418,"twenty":-0.91334,"median":-0.508665,"eighty":-0.331019,"marketCap":2610860},{"date":"2024-08-02","current":-0.272562,"twenty":-0.913129,"median":-0.507585,"eighty":-0.329729,"marketCap":2292462},{"date":"2024-08-09","current":-0.248051,"twenty":-0.911177,"median":-0.505359,"eighty":-0.325114,"marketCap":2086300},{"date":"2024-08-16","current":-0.24035,"twenty":-0.906543,"median":-0.501744,"eighty":-0.319687,"marketCap":1989587},{"date":"2024-08-23","current":-0.293286,"twenty":-0.905493,"median":-0.497744,"eighty":-0.316091,"marketCap":2427781},{"date":"2024-08-30","current":-0.286555,"twenty":-0.903919,"median":-0.49203,"eighty":-0.313322,"marketCap":2372062},{"date":"2024-09-06","current":-0.383339,"twenty":-0.901905,"median":-0.490945,"eighty":-0.313073,"marketCap":3173230},{"date":"2024-09-13","current":-0.311556,"twenty":-0.894391,"median":-0.486542,"eighty":-0.313073,"marketCap":2579020},{"date":"2024-09-20","current":-0.276506,"twenty":-0.893083,"median":-0.485429,"eighty":-0.309761,"marketCap":2288880},{"date":"2024-09-27","current":-0.252418,"twenty":-0.880828,"median":-0.484661,"eighty":-0.307436,"marketCap":2089484},{"date":"2024-10-04","current":-0.23434,"twenty":-0.872964,"median":-0.484601,"eighty":-0.302929,"marketCap":1939837},{"date":"2024-10-11","current":-0.252827,"twenty":-0.865099,"median":-0.482434,"eighty":-0.301027,"marketCap":2092867},{"date":"2024-10-18","current":-0.317326,"twenty":-0.857235,"median":-0.47841,"eighty":-0.300426,"marketCap":2626780},{"date":"2024-10-25","current":-0.39995,"twenty":-0.857235,"median":-0.476537,"eighty":-0.300426,"marketCap":3310734},{"date":"2024-10-31","current":-0.494182,"twenty":-0.850943,"median":-0.478071,"eighty":-0.300907,"marketCap":4090778},{"date":"2024-11-08","current":-0.422626,"twenty":-0.840642,"median":-0.476351,"eighty":-0.301191,"marketCap":3498446},{"date":"2024-11-15","current":-0.352287,"twenty":-0.834605,"median":-0.468894,"eighty":-0.301334,"marketCap":3065275},{"date":"2024-11-22","current":-0.359821,"twenty":-0.830942,"median":-0.464302,"eighty":-0.301657,"marketCap":3130826},{"date":"2024-11-29","current":-0.348213,"twenty":-0.815329,"median":-0.462,"eighty":-0.30245,"marketCap":3029832},{"date":"2024-12-06","current":-0.435267,"twenty":-0.804556,"median":-0.461782,"eighty":-0.30359,"marketCap":3787290},{"date":"2024-12-13","current":-0.420758,"twenty":-0.775862,"median":-0.460599,"eighty":-0.304922,"marketCap":3661047},{"date":"2024-12-20","current":-0.375374,"twenty":-0.755346,"median":-0.458782,"eighty":-0.305517,"marketCap":3266158},{"date":"2024-12-27","current":-0.324419,"twenty":-0.754181,"median":-0.457684,"eighty":-0.304625,"marketCap":2822793},{"date":"2025-01-03","current":-0.389709,"twenty":-0.753938,"median":-0.457139,"eighty":-0.305517,"marketCap":3390886},{"date":"2025-01-10","current":-0.36162,"twenty":-0.752966,"median":-0.455912,"eighty":-0.305517,"marketCap":3146480},{"date":"2025-01-17","current":-0.342177,"twenty":-0.750208,"median":-0.452331,"eighty":-0.307436,"marketCap":2977309},{"date":"2025-01-24","current":-0.238758,"twenty":-0.74342,"median":-0.451013,"eighty":-0.307052,"marketCap":2077454},{"date":"2025-01-31","current":-0.167665,"twenty":-0.737124,"median":-0.449377,"eighty":-0.30269,"marketCap":1458864},{"date":"2025-02-07","current":-0.757086,"twenty":-0.737124,"median":-0.448569,"eighty":-0.301334,"marketCap":6587465},{"date":"2025-02-14","current":-0.783111,"twenty":-0.74342,"median":-0.449855,"eighty":-0.301657,"marketCap":6813909},{"date":"2025-02-21","current":-0.78737,"twenty":-0.751311,"median":-0.451168,"eighty":-0.30245,"marketCap":6850964},{"date":"2025-02-28","current":-0.840366,"twenty":-0.753452,"median":-0.452677,"eighty":-0.30359,"marketCap":7312086},{"date":"2025-03-07","current":-0.710242,"twenty":-0.753452,"median":-0.457022,"eighty":-0.304922,"marketCap":6179866},{"date":"2025-03-14","current":-0.697939,"twenty":-0.751311,"median":-0.45752,"eighty":-0.305517,"marketCap":6072819},{"date":"2025-03-21","current":-0.666099,"twenty":-0.746669,"median":-0.458782,"eighty":-0.306668,"marketCap":5969890},{"date":"2025-03-28","current":-0.654614,"twenty":-0.742758,"median":-0.460599,"eighty":-0.307522,"marketCap":5866961},{"date":"2025-04-04","current":-0.597422,"twenty":-0.741572,"median":-0.462322,"eighty":-0.30825,"marketCap":5354374},{"date":"2025-04-11","current":-0.360284,"twenty":-0.741572,"median":-0.462,"eighty":-0.309143,"marketCap":3229031},{"date":"2025-04-17","current":-0.393753,"twenty":-0.739272,"median":-0.460599,"eighty":-0.309568,"marketCap":3528996},{"date":"2025-04-25","current":-0.435271,"twenty":-0.735618,"median":-0.459466,"eighty":-0.310024,"marketCap":3901103},{"date":"2025-05-02","current":-0.433456,"twenty":-0.734421,"median":-0.458108,"eighty":-0.310681,"marketCap":3884836},{"date":"2025-05-09","current":-0.410992,"twenty":-0.733427,"median":-0.457352,"eighty":-0.311268,"marketCap":3683507},{"date":"2025-05-16","current":-0.433495,"twenty":-0.733238,"median":-0.456951,"eighty":-0.312163,"marketCap":4528878},{"date":"2025-05-23","current":-0.476844,"twenty":-0.73159,"median":-0.457022,"eighty":-0.313182,"marketCap":4981766},{"date":"2025-05-30","current":-0.510623,"twenty":-0.72928,"median":-0.457352,"eighty":-0.313539,"marketCap":5334665},{"date":"2025-06-06","current":-0.492889,"twenty":-0.726897,"median":-0.458108,"eighty":-0.314338,"marketCap":5149393},{"date":"2025-06-13","current":-0.476844,"twenty":-0.721599,"median":-0.460002,"eighty":-0.314632,"marketCap":4981766},{"date":"2025-06-20","current":-0.472762,"twenty":-0.721599,"median":-0.461082,"eighty":-0.315448,"marketCap":4939123},{"date":"2025-06-27","current":-0.547779,"twenty":-0.720641,"median":-0.462644,"eighty":-0.316082,"marketCap":5722855},{"date":"2025-07-03","current":-0.495422,"twenty":-0.717621,"median":-0.464343,"eighty":-0.316116,"marketCap":5175860},{"date":"2025-07-11","current":-0.507256,"twenty":-0.713373,"median":-0.4685,"eighty":-0.316507,"marketCap":5299493},{"date":"2025-07-18","current":-0.492044,"twenty":-0.712018,"median":-0.468907,"eighty":-0.317181,"marketCap":5140570},{"date":"2025-07-25","current":-0.481629,"twenty":-0.711655,"median":-0.470834,"eighty":-0.318566,"marketCap":5031760},{"date":"2025-08-01","current":-0.377197,"twenty":-0.710512,"median":-0.468907,"eighty":-0.319132,"marketCap":3940712},{"date":"2025-08-08","current":-0.389019,"twenty":-0.709863,"median":-0.4685,"eighty":-0.31949,"marketCap":4064227},{"date":"2025-08-15","current":-0.353066,"twenty":-0.70693,"median":-0.464343,"eighty":-0.320061,"marketCap":4296552},{"date":"2025-08-22","current":-0.351906,"twenty":-0.703381,"median":-0.462322,"eighty":-0.321248,"marketCap":4282436},{"date":"2025-08-29","current":-0.36249,"twenty":-0.700976,"median":-0.460599,"eighty":-0.322147,"marketCap":4411245},{"date":"2025-09-05","current":-0.368517,"twenty":-0.699677,"median":-0.459955,"eighty":-0.323573,"marketCap":4484589},{"date":"2025-09-12","current":-0.364907,"twenty":-0.698401,"median":-0.459424,"eighty":-0.324593,"marketCap":4440653},{"date":"2025-09-19","current":-0.386656,"twenty":-0.697939,"median":-0.457848,"eighty":-0.325298,"marketCap":4705328},{"date":"2025-09-26","current":-0.35814,"twenty":-0.697858,"median":-0.457139,"eighty":-0.326095,"marketCap":4358310},{"date":"2025-10-03","current":-0.353066,"twenty":-0.694336,"median":-0.454873,"eighty":-0.326416,"marketCap":4296552},{"date":"2025-10-10","current":-0.394389,"twenty":-0.691173,"median":-0.452245,"eighty":-0.32662,"marketCap":4799434},{"date":"2025-10-17","current":-0.654416,"twenty":-0.697858,"median":-0.454873,"eighty":-0.32682,"marketCap":7963767},{"date":"2025-10-24","current":-0.647649,"twenty":-0.698401,"median":-0.457139,"eighty":-0.327094,"marketCap":7881424},{"date":"2025-10-31","current":-0.566171,"twenty":-0.697939,"median":-0.457848,"eighty":-0.328539,"marketCap":6889891},{"date":"2025-11-07","current":-0.424876,"twenty":-0.697858,"median":-0.45875,"eighty":-0.329896,"marketCap":5170435},{"date":"2025-11-14","current":-0.817796,"twenty":-0.698401,"median":-0.459476,"eighty":-0.3307,"marketCap":11259057},{"date":"2025-11-21","current":-1.122489,"twenty":-0.704091,"median":-0.460563,"eighty":-0.331151,"marketCap":15453937},{"date":"2025-11-28","current":-1.325415,"twenty":-0.711053,"median":-0.461782,"eighty":-0.331323,"marketCap":18247728},{"date":"2025-12-05","current":-1.152349,"twenty":-0.717675,"median":-0.464302,"eighty":-0.331469,"marketCap":15865036},{"date":"2025-12-12","current":-0.692263,"twenty":-0.721216,"median":-0.467711,"eighty":-0.331585,"marketCap":9530767},{"date":"2025-12-19","current":-0.842172,"twenty":-0.721599,"median":-0.46888,"eighty":-0.33172,"marketCap":11594648},{"date":"2025-12-26","current":-0.847047,"twenty":-0.72928,"median":-0.468962,"eighty":-0.331777,"marketCap":11661766},{"date":"2026-01-02","current":-0.879344,"twenty":-0.733427,"median":-0.471638,"eighty":-0.331963,"marketCap":12106423},{"date":"2026-01-09","current":-0.801343,"twenty":-0.736748,"median":-0.472832,"eighty":-0.332335,"marketCap":11032534},{"date":"2026-01-16","current":-0.649606,"twenty":-0.736748,"median":-0.475311,"eighty":-0.333246,"marketCap":8943484},{"date":"2026-01-23","current":-0.588667,"twenty":-0.736748,"median":-0.476722,"eighty":-0.334203,"marketCap":8104508},{"date":"2026-01-30","current":-0.505791,"twenty":-0.736129,"median":-0.476844,"eighty":-0.335031,"marketCap":6963500},{"date":"2026-02-06","current":-0.47654,"twenty":-0.735261,"median":-0.476844,"eighty":-0.33585,"marketCap":6560792},{"date":"2026-02-13","current":-0.503962,"twenty":-0.733758,"median":-0.476783,"eighty":-0.336018,"marketCap":6938331},{"date":"2026-02-20","current":-0.571604,"twenty":-0.733427,"median":-0.476844,"eighty":-0.336023,"marketCap":7869594},{"date":"2026-02-27","current":-0.518588,"twenty":-0.733143,"median":-0.477407,"eighty":-0.336816,"marketCap":7139685},{"date":"2026-03-06","current":-1.048021,"twenty":-0.733427,"median":-0.47819,"eighty":-0.338102,"marketCap":14428683},{"date":"2026-03-13","current":-0.989322,"twenty":-0.736748,"median":-0.478533,"eighty":-0.338728,"marketCap":13620542},{"date":"2026-03-20","current":-1.010111,"twenty":-0.742658,"median":-0.479947,"eighty":-0.339098,"marketCap":13906759},{"date":"2026-03-27","current":-0.805879,"twenty":-0.753452,"median":-0.481629,"eighty":-0.339386,"marketCap":12736638},{"date":"2026-04-02","current":-0.645555,"twenty":-0.754181,"median":-0.482671,"eighty":-0.339473,"marketCap":10202779},{"date":"2026-04-10","current":-0.655048,"twenty":-0.754181,"median":-0.484263,"eighty":-0.339808,"marketCap":10352813},{"date":"2026-04-17","current":-0.750909,"twenty":-0.753695,"median":-0.484601,"eighty":-0.340345,"marketCap":11867859},{"date":"2026-04-24","current":-0.653907,"twenty":-0.752143,"median":-0.484722,"eighty":-0.340522,"marketCap":10334776},{"date":"2026-05-01","current":-0.739497,"twenty":-0.750629,"median":-0.485839,"eighty":-0.340636,"marketCap":11687496},{"date":"2026-05-08","current":-0.726944,"twenty":-0.747849,"median":-0.486634,"eighty":-0.340703,"marketCap":11489097},{"date":"2026-05-15","current":-0.616771,"twenty":-0.74421,"median":-0.488728,"eighty":-0.340703,"marketCap":10479067},{"date":"2026-05-22","current":-0.51486,"twenty":-0.743126,"median":-0.48955,"eighty":-0.340718,"marketCap":8747586},{"date":"2026-05-29","current":-0.524414,"twenty":-0.741673,"median":-0.490945,"eighty":-0.340743,"marketCap":8909912},{"date":"2026-06-05","current":-0.455413,"twenty":-0.741304,"median":-0.490945,"eighty":-0.340807,"marketCap":7737555},{"date":"2026-06-12","current":-0.498937,"twenty":-0.74041,"median":-0.490945,"eighty":-0.341072,"marketCap":8477042},{"date":"2026-06-18","current":-0.546131,"twenty":-0.739497,"median":-0.491213,"eighty":-0.341224,"marketCap":9278886},{"date":"2026-06-26","current":-0.496483,"twenty":-0.73803,"median":-0.491481,"eighty":-0.341735,"marketCap":8435351},{"date":"2026-07-02","current":-0.55677,"twenty":-0.737378,"median":-0.492044,"eighty":-0.342089,"marketCap":9459644},{"date":"2026-07-10","current":-0.552042,"twenty":-0.736841,"median":-0.492895,"eighty":-0.342178,"marketCap":9379307},{"date":"2026-07-17","current":-0.491755,"twenty":-0.736748,"median":-0.493447,"eighty":-0.343435,"marketCap":8355014},{"date":"2026-07-24","current":-0.516579,"twenty":-0.736129,"median":-0.495,"eighty":-0.344984,"marketCap":8776782},{"date":"2026-07-31","current":-0.520125,"twenty":-0.735439,"median":-0.495731,"eighty":-0.345304,"marketCap":8837034},{"date":"2026-08-07","current":-0.540221,"twenty":-0.734992,"median":-0.496483,"eighty":-0.345469,"marketCap":9178465},{"date":"2026-08-14","current":-0.715172,"twenty":-0.734247,"median":-0.497419,"eighty":-0.345574,"marketCap":12150922},{"date":"2026-08-21","current":-0.536932,"twenty":-0.733573,"median":-0.498316,"eighty":-0.345799,"marketCap":10022000}],"updateTime":1787438139086},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"QNRX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2644086923","title":"Quoin Pharmaceuticals Completes Establishment Of Japanese Subsidiary To Advance Commercial Readiness For Qrx003","url":"https://stock-news.laohu8.com/highlight/detail?id=2644086923","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644086923?lang=en_us&edition=fundamental","pubTime":"2026-06-18 21:07","pubTimestamp":1781788069,"startTime":"0","endTime":"0","summary":"June 18 (Reuters) - Quoin Pharmaceuticals Ltd <2EB0y.F>::*QUOIN PHARMACEUTICALS COMPLETES ESTABLISHMENT OF JAPANESE SUBSIDIARY TO ADVANCE COMMERCIAL READINESS FOR QRX003*QUOIN PHARMACEUTICALS - TO INI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nRSD7YHktZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644823085","title":"Quoin Pharmaceuticals establishes Japan subsidiary to support QRX003 commercialization plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2644823085","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644823085?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:31","pubTimestamp":1781785861,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals completed the establishment of a wholly owned subsidiary in Japan to support a planned direct launch of QRX003.Move strengthens commercial readiness in a core market following Japanese orphan-drug designation for QRX003 in Netherton syndrome.Japan subsidiary adds to a self-commercialization strategy in the US and Western Europe; partnerships cover 61 countries outside core territories.QRX003 is in Phase 2 whole-body trials; a pivotal Phase 3 study is slated for 2H 2026 with a potential NDA filing in 2027.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL5cvBjH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014005.SGD","SG9999014013.SGD","NDAQ","IE00BGHQF748.EUR","LU0314104364.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BN0W2V16.EUR","LU2095319765.USD","BK4585","IE00BN0W2W23.USD","BK4139","BK4588","QNRX","SG9999014021.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4112","IE00B3QW5Z07.USD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643142750","title":"Quoin reports positive pediatric data in Netherton Syndrome program","url":"https://stock-news.laohu8.com/highlight/detail?id=2643142750","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643142750?lang=en_us&edition=fundamental","pubTime":"2026-06-16 21:18","pubTimestamp":1781615915,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (QNRX) announced a positive clinical update from its ongoing pediatric Netherton Syndrome Compassionate Use program evaluatin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-reports-positive-pediatric-data-in-netherton-syndrome-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-reports-positive-pediatric-data-in-netherton-syndrome-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643275247","title":"Quoin says QRX003 improves 4 of 6 pediatric Netherton syndrome patients in compassionate use program","url":"https://stock-news.laohu8.com/highlight/detail?id=2643275247","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643275247?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:31","pubTimestamp":1781613104,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals reported a positive interim update from its pediatric compassionate-use program for QRX003 in Netherton syndrome.Most enrolled children were assessed as improved versus baseline across key clinical endpoints, supporting the drug’s potential in a core patient group.No treatment-related adverse events were reported in the cohort to date.A broader clinical data release, including results from ongoing Phase 2 studies, is scheduled for the coming months.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDLSxMCJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2095319765.USD","LU2210149790.SGD","IE00BKPKM429.USD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU0314104364.USD","SG9999014039.USD","BK4588","QNRX","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","SG9999014005.SGD","NDAQ","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4139","SG9999014021.USD","BK4112","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643527577","title":"Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2643527577","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643527577?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:30","pubTimestamp":1781613000,"startTime":"0","endTime":"0","summary":"Four of Six Patients Participating in the Compassionate Use Program Were Classified as‘Improved’ or ‘Significantly Improved’ from Baseline Assessment Across Key Clinical Endpoints All Six Patients Are","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/16/3312590/0/en/Quoin-Pharmaceuticals-Announces-Positive-Clinical-Update-from-Ongoing-Pediatric-Netherton-Syndrome-Compassionate-Use-Program.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IGA","BK4139","QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640615042","title":"Quoin Pharmaceuticals' Skin Disorder Drug Receives Orphan Drug Designation in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2640615042","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640615042?lang=en_us&edition=fundamental","pubTime":"2026-06-04 21:03","pubTimestamp":1780578200,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals  said Thursday that Japan's Ministry of Health, Labour and Welfare has granted orphan drug designation to its experimental drug, QRX003, for the treatment of Netherton Syndrome.The company said the designation provides development incentives such as regulatory support, reduced fees, priority review, tax benefits, and up to 10 years of market exclusivity if approved.QRX003 is currently being evaluated in mid-stage studies, with a pivotal late-stage trial expected to begin in H2, Quoin said, adding that a US regulatory filing could follow next year.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640615745","title":"Quoin says Japan MHLW grants orphan drug status to QRX003 for Netherton syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2640615745","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640615745?lang=en_us&edition=fundamental","pubTime":"2026-06-04 20:32","pubTimestamp":1780576379,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals said Japan’s MHLW granted orphan drug designation for QRX003 to treat Netherton syndrome.Designation offers development incentives in Japan, including up to 10 years of market exclusivity on approval.Phase 3 trial expected to start in H2 2026; NDA filing targeted for 2027.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL7WzhZk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","QNRX","LU2210149790.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4112","LU2095319765.USD","BK4139","BK4585","NDAQ","LU2210150020.SGD","SG9999014021.USD","LU0314104364.USD","SG9999014005.SGD","IE00B64PRP62.GBP","BK4588","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","SG9999014039.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640894906","title":"Quoin Pharmaceuticals submits QRX003 IND application to FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2640894906","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640894906?lang=en_us&edition=fundamental","pubTime":"2026-06-02 22:36","pubTimestamp":1780410980,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (QNRX) announced the submission of an investigational new drug, or IND, application to the FDA for QRX003 for the treatment o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-submits-qrx003-ind-application-to-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-submits-qrx003-ind-application-to-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","QNRX","IND","BK4585","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640480899","title":"Quoin Pharmaceuticals submits FDA IND for QRX003 in Peeling Skin Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2640480899","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640480899?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:32","pubTimestamp":1780403571,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals submitted an FDA IND for QRX003 to treat Peeling Skin Syndrome, a rare disease with no approved therapy.FDA review is pending; a Phase 2 study is targeted for the second half of 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL7Gx8gC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014021.USD","BK4588","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2W23.USD","QNRX","IE00BKPKM429.USD","NDAQ","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","BK4112","BK4139","LU2210149790.SGD","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634028468","title":"Quoin Pharmaceuticals (QNRX) Receives a Buy from Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2634028468","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634028468?lang=en_us&edition=fundamental","pubTime":"2026-05-08 23:55","pubTimestamp":1778255718,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Naz Rahman reiterated a Buy rating on Quoin Pharmaceuticals yesterday and set a price target of $40.00. Rahman covers the Healt...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/quoin-pharmaceuticals-qnrx-receives-a-buy-from-maxim-group-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/quoin-pharmaceuticals-qnrx-receives-a-buy-from-maxim-group-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633314243","title":"Quoin Pharmaceuticals Q1 EPS $(1.77) Misses $(1.72) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633314243","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633314243?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:32","pubTimestamp":1778157167,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.77) per share which missed the analyst consensus estimate of $(1.72) by 2.91 percent. This is a 72.77 percent increase over losses of $(6.50) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52364293/quoin-pharmaceuticals-q1-eps-1-77-misses-1-72-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633914226","title":"Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633914226","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633914226?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:30","pubTimestamp":1778157000,"startTime":"0","endTime":"0","summary":"– Filed Breakthrough Medicine Designation Application with Saudi FDA for QRX003 in Netherton Syndrome  – Submitted Application to Japanese MHLW for Orphan Drug Designation (ODD) for QRX003; MHLW Confi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3290007/0/en/Quoin-Pharmaceuticals-Provides-Corporate-Update-and-Reports-First-Quarter-2026-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","LABU","BK4139","BK4588","ODD","QNRX","BK4585","IE0009354923.USD","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633949173","title":"Quoin Pharmaceuticals Ltd  expected to post a loss of $1.93 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633949173","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633949173?lang=en_us&edition=fundamental","pubTime":"2026-05-05 22:33","pubTimestamp":1777991584,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd  expected to post a loss of $1.93 a share - Earnings Preview Quoin Pharmaceuticals Ltd QNRX.OQ, QNRX.O is expected to  show no change in quarterly revenue when it reports  re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL8N41I27C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633957554","title":"Quoin Pharmaceuticals Initiated at Buy by LUCID CAPITAL MARKETS","url":"https://stock-news.laohu8.com/highlight/detail?id=2633957554","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633957554?lang=en_us&edition=fundamental","pubTime":"2026-05-05 01:13","pubTimestamp":1777914780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/QNRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 04, 2026 13:13 ET (17:13 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632932880","title":"Quoin Pharmaceuticals initiated with a Buy at Lucid Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2632932880","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632932880?lang=en_us&edition=fundamental","pubTime":"2026-05-04 18:11","pubTimestamp":1777889474,"startTime":"0","endTime":"0","summary":"Lucid Capital initiated coverage of Quoin Pharmaceuticals (QNRX) with a Buy rating and $30 price target Quoin is a late-stage clinical specialty ph...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-initiated-with-a-buy-at-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-initiated-with-a-buy-at-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCIZ","BK4555","BK4596","LCID","BK4139","BK4099","LCDL","QNRX","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631163275","title":"Quoin Pharma to report Q1 results, provide corporate update May 7","url":"https://stock-news.laohu8.com/highlight/detail?id=2631163275","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631163275?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:33","pubTimestamp":1777552399,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals will release first-quarter 2026 financial results before market open on Thursday, May 7, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL53lGLT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU0314104364.USD","SG9999014021.USD","NDAQ","LU2095319765.USD","SG9999014039.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","LU2210149790.SGD","BK4588","BK4139","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014005.SGD","BK4585","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","QNRX","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630588449","title":"Quoin Pharmaceuticals Provides Clinical And Regulatory Update For Qrx009 Topical Rapamycin Development Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2630588449","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630588449?lang=en_us&edition=fundamental","pubTime":"2026-04-28 21:55","pubTimestamp":1777384522,"startTime":"0","endTime":"0","summary":"April 28 (Reuters) - Quoin Pharmaceuticals Ltd <2EB0y.F>::*QUOIN PHARMACEUTICALS PROVIDES CLINICAL AND REGULATORY UPDATE FOR QRX009 TOPICAL RAPAMYCIN DEVELOPMENT PROGRAMS*QUOIN PHARMACEUTICALS LTD - T","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nRSD2DHyyQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630047183","title":"Quoin plans investigator-led trial of QRX009 topical rapamycin in pachyonychia congenita","url":"https://stock-news.laohu8.com/highlight/detail?id=2630047183","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630047183?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:35","pubTimestamp":1777379739,"startTime":"0","endTime":"0","summary":"Quoin outlined plans to launch several investigator-led clinical studies for QRX009 topical rapamycin, with no trial results presented to date.First study targets pachyonychia congenita, with initiation targeted for Q3 2026.Additional investigator-led studies in Gorlin syndrome and tuberous sclerosis complex are planned later in 2026 to broaden QRX009 clinical readouts.Regulatory strategy includes filing an FDA investigational new drug application for QRX009 in an additional indication in Q3 2026.Management expects QRX009 could be in active testing across four indications before end-2026, positioning it as a pipeline expansion alongside ongoing late-stage work in Netherton syndrome.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quoin ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL8rmx47:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630472304","title":"Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2630472304","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630472304?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:30","pubTimestamp":1777379400,"startTime":"0","endTime":"0","summary":"Company Planning Multi-Pronged Approach for QRX009 Including Several Investigator Led Clinical Studies in Key Indications.  Company to Initiate Investigator Led Clinical Study in Pachyonychia Congenit","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/28/3282671/0/en/Quoin-Pharmaceuticals-Provides-Clinical-and-Regulatory-Update-for-QRX009-Topical-Rapamycin-Development-Programs.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868837136.USD","LU0345770308.USD","IE00BSNM7G36.USD","LU2237438978.USD","BK4550","LU1668664300.SGD","BK4139","IE00B19Z3B42.SGD","LU2265009873.SGD","IE00B19Z3581.USD","LU0048573561.USD","BK4516","LU2237443978.SGD","QNRX","LU0251142724.SGD","LU2237443622.USD","IE0034235188.USD","LU1868837300.USD","LU0251131958.USD","LU2750360641.GBP","IE0004086264.USD","LU2471134879.HKD","LU2471134796.USD","LU2750360997.AUD","LU2237443549.SGD","IND","GSX","LU1894683264.USD","LU2237443382.USD","LU0106831901.USD","LU1868836591.USD","BK4585","LU0345770993.USD","LU0061475181.USD","IE00BFXG1179.USD","LU1804176565.USD","LU2237443895.HKD","LU1791807156.HKD","LU1868836914.USD","LU1868836757.USD","BK4504","LU2471134952.CNY","BK4552","LU1894683348.USD","BK4209","IE0004091025.USD","BK4588","BK4533","PC","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629005608","title":"Quoin’s QRX003 Trial Moves Forward In Rare Skin Disease, Keeping QNRX On Investor Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2629005608","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629005608?lang=en_us&edition=fundamental","pubTime":"2026-04-22 00:31","pubTimestamp":1776789083,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd ($QNRX) announced an update on their ongoing clinical study. The multicenter study “A Multicenter, Open-label Study of QR...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/quoins-qrx003-trial-moves-forward-in-rare-skin-disease-keeping-qnrx-on-investor-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/quoins-qrx003-trial-moves-forward-in-rare-skin-disease-keeping-qnrx-on-investor-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":59,"code":"91000000","status":"200"}]}}